Resolving power of dynamic light scattering for protein and polystyrene nanoparticles

Pharmaceutical Development and Technology

Volumn 20, Issue 1, 2015, Pages 84-89

  Karow, Anne R ^a   Götzl, Jana ^a   Garidel, Patrick ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Antibody; Cross linking; Particle sizing; Photon correlation spectroscopy; Protein aggregation; Reference materials

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; MONOMER; NANOPARTICLE; POLYSTYRENE; PROTEIN; ALBUMINOID; CROSS LINKING REAGENT; POLYSTYRENE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; DYNAMIC LIGHT SCATTERING; OPTICAL RESOLUTION; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN AGGREGATION; QUANTITATIVE ANALYSIS; STANDARD; ALGORITHM; CHEMISTRY; LIGHT;

ALBUMINS; ALGORITHMS; CROSS-LINKING REAGENTS; DYNAMIC LIGHT SCATTERING; IMMUNOGLOBULIN G; LIGHT; NANOPARTICLES; PARTICLE SIZE; POLYSTYRENES; PROTEINS;

EID: 84921275313     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2014.910808     Document Type: Article

References (32)

1. Berne BJ, Pecora R. Dynamic light scattering: with applications to chemistry, biology, and physics. Mineola: Dover Publications; 2000.
2. Brown W. Dynamic light scattering: the method and some applications. Oxford: Clarendon Press; 1993.
3. Liao JH, Lee JS, Chiou SH. Distinct roles of alphaA- and alphaBcrystallins under thermal and UV stresses. Biochem Biophys Res Commun 2002;295:854-861.
4. Georgieva D, Schwark D, von BM, et al. Interactions of recombinant prions with compounds of therapeutical significance. Biochem Biophys Res Commun 2006;344:463-470.
5. Suzuki S, Wilson-Kubalek EM, Wert D, et al. The oligomeric structure of high molecular weight adiponectin. FEBS Lett 2007;581:809-814.
6. Li Y, Lubchenko V, Vekilov PG. The use of dynamic light scattering and Brownian microscopy to characterize protein aggregation. Rev Sci Instrum 2011;82:053106. doi: 10.1063/1.3592581.
7. Galantai R, Modos K, Fidy J, et al. Structural basis of the cofactor function of denatured albumin in plasminogen activation by tissuetype plasminogen activator. Biochem Biophys Res Commun 2006;341:736-741.
8. Lind J, Lindahl E, Perálvarez-Marín A, et al. Structural features of proinsulin C-peptide oligomeric and amyloid states. FEBS J 2010;277:3759-3768.
9. Garidel P, Kebbel F. Protein therapeutics and aggregates characterized by photon correlation spectroscopy. Bioprocess Int 2010;8:38-46.
10. Carpenter JF, Randolph TW, Jiskoot W, et al. Potential inaccurate quantitation and sizing of protein aggregates by size exclusion chromatography: essential need to use orthogonal methods to assure the quality of therapeutic protein products. J Pharm Sci 2010;99:2200-2208.
11. Zölls S, Tantipolphan R, Wiggenhorn M, et al. Particles in therapeutic protein formulations, Part 1: overview of analytical methods. J Pharm Sci 2012;101:914-935.
12. den Engelsman J, Garidel P, Smulders R, et al. Strategies for the assessment of protein aggregates in pharmaceutical biotech product development. Pharm Res 2011;28:920-933.
13. Narhi LO, Schmit J, Bechtold-Peters K, Sharma D. Classification of protein aggregates. J Pharm Sci 2012;101:493-498.
14. Rosenberg AS. Effects of protein aggregates: an immunologic perspective. AAPS J 2006;8:E501-E507.
15. Carpenter JF, Randolph TW, Jiskoot W, et al. Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. J Pharm Sci 2009;98:1201-1205.
16. Kaszuba M, Connah MT, Neil-Watson FK, Nobbmann U. Resolving concentrated particle size mixtures using dynamic light scattering. Part Part Syst Charact 2007;24:159-162.
17. Filipe V, Hawe A, Jiskoot W. Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 2010;27:796-810.
18. Jamting AK, Cullen J, Coleman VA, et al. Systematic study of bimodal suspensions of latex nanoparticles using dynamic light scattering. Adv Powder Technol 2011;22:290-293.
19. Hanus LH, Ploehn HJ. Conversion of intensity-averaged photon correlation spectroscopy measurements to number-averaged particle size distributions. 1. Theoretical development. Langmuir 1999;15:3091-3100.
20. Arakawa T, Philo JS, Ejima D, et al. Aggregation analysis of therapeutic proteins, Part 2. BioProcess Int 2007;5:36-47.
21. Finsy R, Deriemaeker L, De Jaeger N, et al. Particle sizing by photon correlation spectroscopy. Part IV; resolution of bimodals and comparison with other particle sizing methods. Part Part Syst Charact 1993;10:118-128.
22. Rasteiro MG, Lemos CC, Vasquez A. Nanoparticle characterization by PCS: the analysis of bimodal distributions. Part Sci Technol 2008;26:413-437.
23. International Organization for Standardization (ISO). ISO13321 IS. 1996.
24. Bergemann K, Eckermann C, Garidel P, et al. Production and downstream processing. In: Dübel S, ed. Handbook of therapeutic antibodies. Weinheim: John Wiley & Sons; 2007:199-238.
25. Xu R. Particle characterization: light scattering methods. Dordrecht: Kluwer Academic; 2000.
26. den Engelsman J, Kebbel F, Garidel P. Laser light scattering-based techniques used for the characterisation of protein therapeutics. In: Mahler HC, Jiskoot W, ed. Analysis of aggregates and particles in protein pharmaceuticals. Chapter 3. New Jersey: John Wiley & Sons; 2012:37-60.
27. Ripple DC, Wayment JR, Carrier MJ. Standards for the optical detection of protein particles. Am Pharma Rev 2011;14:90-96.
28. Garidel P, Herre A, Kliche W. Microscopic methods for particle characterisation in protein pharmaceuticals. In: Mahler HC, Jiskoot W, eds. Analysis of aggregates and particles in protein pharmaceuticals. Chapter 12. New Jersey: John Wiley & Sons; 2012:269-302.
29. Foladori P, Quaranta A, Ziglio G. Use of silica microspheres having refractive index similar to bacteria for conversion of flow cytometric forward light scatter into biovolume. Water Res 2008;42:3757-3766.
30. Chandler WL, Yeung W, Tait JF. A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer. J Thromb Haemost 2011;9:1216-1224.
31. Barnard JG, Singh S, Randolph TW, Carpenter JF. Subvisible particle counting provides a sensitive method of detecting and quantifying aggregation of monoclonal antibody caused by freezethawing: insights into the roles of particles in the protein aggregation pathway. J Pharm Sci 2011;100:492-503.
32. Brummitt RK, Nesta DP, Chang L, et al. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates. J Pharm Sci 2011;100:2087-2103.